• Home
  •  / Taysha Gene Therapies

Taysha Gene Therapies

OverviewSuggest Edit

Taysha Gene Therapies is a biotechnology company. It develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system (CNS).
TypePrivate
Founded2020
HQDallas, USMap
Websitetayshagtx.com

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2020)11(+58%)
Cybersecurity ratingAMore

Taysha Gene Therapies Office Locations

Taysha Gene Therapies has an office in Dallas
Dallas, US (HQ)
2280 Inwood Rd
Show all (1)

Taysha Gene Therapies Financials and Metrics

Summary Metrics

Founding Date

2020

Taysha Gene Therapies total Funding

$125 m

Taysha Gene Therapies latest funding size

$95 m

Time since last funding

3 months ago

Taysha Gene Therapies investors

Sands Capital Ventures, Invus, Perceptive Advisors, GV, PBM Capital Group, Venrock Healthcare Partners, Nolan Capital
Taysha Gene Therapies's latest funding round in August 2020 was reported to be $95 m. In total, Taysha Gene Therapies has raised $125 m
Show all financial metrics

Taysha Gene Therapies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

Learn more about about our premium products
SecurityScorecard logo

Taysha Gene Therapies Online and Social Media Presence

Taysha Gene Therapies's Trends

Embed Graph

Taysha Gene Therapies News and Updates

September 17, 2020

Taysha Gene Therapies sets IPO terms, could be valued at up to $690.4 million

Taysha Gene Therapies Inc. set terms Thursday for its initial public offering, as the Dallas-based company focused on treatments for central nervous system diseases looks to raise up to $131.6 million. The company is offering 6,578,970 shares in the IPO, which is expected to price between $18 and $…
April 29, 2020

Taysha Gene Therapies Raises $30M in Seed Financing

Taysha Gene Therapies, a Dallas, TX-based developer of treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system (CNS), raised $30m in seed funding. The round was co-led by PBM Capital and Nolan Capital.

 Taysha Gene Therapies Frequently Asked Questions

  • When was Taysha Gene Therapies founded?

    Taysha Gene Therapies was founded in 2020.

  • How many employees does Taysha Gene Therapies have?

    Taysha Gene Therapies has 11 employees.

  • Who are Taysha Gene Therapies competitors?

    Competitors of Taysha Gene Therapies include New England Biolabs, Synthomics and eGenesis.

  • Where is Taysha Gene Therapies headquarters?

    Taysha Gene Therapies headquarters is located at 2280 Inwood Rd, Dallas.

  • Where are Taysha Gene Therapies offices?

    Taysha Gene Therapies has an office in Dallas.

  • How many offices does Taysha Gene Therapies have?

    Taysha Gene Therapies has 1 office.